Vanguard vs. Schwab: Which Small-Cap ETF Belongs in Your Portfolio?

Vanguard Small-Cap ETF (VB) has the lower expense ratio at 0.03% versus 0.04% for Schwab U.S. Small-Cap ETF (SCHA), while also managing far more assets at $164.6B vs. $22.0B. SCHA delivered the stronger 1-year total return at 44.1% versus 33.9%, but VB posted a smaller 5-year max drawdown (-28.2% vs. -30.8%) and slightly better $1,000 growth over five years ($1,353 vs. $1,334). The piece is a comparative ETF analysis with limited standalone market-moving impact.

Analysis

The relevant signal is not “which ETF is cheaper,” but that the small-cap complex is still being crowded into a narrow set of high-beta, domestically levered names. That shows up in the top holdings: industrials, power/utilities-like defensives, and selected healthcare/tech rerating names are doing the heavy lifting, while the broad basket remains mediocre underneath. In practice, the stronger recent return in the more diversified vehicle looks less like a structural edge and more like a factor mix benefit from a handful of names that have already de-risked into quality and cash-flow visibility.

The bigger second-order effect is that broad small-cap wrappers are now effectively a financing/liquidity trade on the rate path. If yields stay elevated, the market is likely to keep rewarding balance-sheet quality and free-cash-flow names within small caps, while punishing the weakest profitable-but-not-yet-durable businesses that dominate index breadth. That makes the more concentrated, lower-drawdown basket preferable as a parking vehicle for small-cap exposure, but also raises the odds that the next leg of outperformance comes from active selection rather than passive beta.

Contrarian takeaway: the “broad diversification” pitch for the larger basket may be exactly why it underperforms in a choppy macro tape. Diversification across low-quality small caps dilutes exposure to the few balance-sheet winners that can actually compound if rates remain restrictive for months, not weeks. The sentiment implication is modestly positive for the ETF complex overall, but the real opportunity is to own the quality/FCF subset inside small caps and fade broad, undifferentiated exposure on rallies.

The individual names called out matter more than the wrappers: EME, NRG, and ATO sit in sectors that can still monetize capital discipline, rate resilience, or regulated/contracted cash flows, while SNDK and LITE are more exposed to capex cyclicality and sentiment beta. If the market continues to favor defensives-with-growth over pure cyclicals, those relative winners can keep dragging the basket, but any rotation back to an outright risk-on regime would quickly compress this advantage.

Key Decisions for Investors

• Prefer VB over SCHA for passive small-cap exposure over the next 3-6 months: lower drawdown and better liquidity make it the cleaner implementation, with limited fee difference but better downside control.
• Use a pair trade: long VB / short IWM on a tactical basis if rates stay elevated and breadth remains poor; the thesis is that lower-quality small caps lag while higher-quality names inside VB hold up better. Keep a tight stop if real yields break lower.
• Build a basket long EME, NRG, and ATO for 2-4 quarters as a quality-in-small-caps trade; these names have the best shot at outperformance if the market keeps paying for cash flow visibility and defensive growth.
• Fade any 1-2 day squeeze in SCHA as a broad small-cap beta expression; the upside capture is lower conviction than the downside if market internals roll over.
• If you want convexity, buy a 6-12 month call spread on VB rather than outright equity exposure; the setup favors modest upside with less path dependency than the broader small-cap universe.